For instance, reverse transcription quantitative PCR (RT-qPCR) analysis showed that TUG1 expression was significantly higher in peripheral serum (Santoro et al., 2016; Santoro et al., 2020) and whole blood (Dastmalchi et al., 2018) in patients with MS compared with controls. Here, TUG1 is linked to myeloid sarcoma.